Penserra Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,990
| Closed | -$65K | – | 1363 |
|
|
2021
Q3 | $65K | Buy |
1,990
+160
| +9% | +$5.23K | ﹤0.01% | 968 |
|
|
2021
Q2 | $115K | Buy |
1,830
+15
| +0.8% | +$943 | ﹤0.01% | 756 |
|
|
2021
Q1 | $77K | Buy |
1,815
+65
| +4% | +$2.76K | ﹤0.01% | 740 |
|
|
2020
Q4 | $100K | Buy |
1,750
+1,104
| +171% | +$63.1K | ﹤0.01% | 603 |
|
|
2020
Q3 | $19K | Buy |
+646
| New | +$19K | ﹤0.01% | 743 |
|